Tagged with Investment,

USA David H. Crean, Ph.D., Managing Partner at Cardiff Advisory, provides his insights on the potential impact of the US Federal Trade Commission (FTC)’s antitrust policies on biopharmaceutical mergers and acquisitions. Crean expects to see a continuation of 2023’s strong start to M&A and questions whether the FTC’s newly-aggressive approach will…

Hong Kong As managing director of the CR-CP Life Science Fund, whose shareholders, CR Group and CP Group, are on the Fortune Global 500 List, Da Liu leads investments in life sciences companies globally, especially those in emerging sectors such as RNA therapeutics and cancer screening. In conversation with PharmaBoardroom, Liu discusses…

Hong Kong Tech entrepreneur and investor Duncan Chiu has long been committed to developing local technology and innovation in Hong Kong. He discusses the current blueprint for advancing life sciences, advanced manufacturing, AI, big data and FinTech in the region and the need for government involvement to incentivise investment.   Historically, we…

Belgium Belgium’s Flanders region is a hotbed of biotech excellence, with numerous examples of university spin-offs being translated into commercial-stage companies and many of those later acquired by Big Pharma. Wouter Piepers of cluster organisation flanders.bio outlines the fundamentals behind this success story, and what potential future investors in Belgian biotech…

Hong Kong Professor Michael Yang of City University of Hong Kong (CityU) introduces the ‘HK Tech 300‘ programme he oversees, the largest university-based entrepreneurship programme in Asia. Drawing on his own experience as co-founder of Prenetics and Cellomics, biotech companies based on technologies developed in his laboratory at CityU, Professor Yang assesses…

Hong Kong Hong Kong’s Secretary for Innovation, Technology and Industry since July 2022, Professor Dong SUN is a pioneer in robotic manipulation of biological cells and robot control, whose research has led to breakthroughs in the use of robotics combined with various micro-engineering tools. Now with responsibility for developing Hong Kong into…

Hong Kong Former chief executive of the Hong Kong Special Administrative Region (HKSAR) Leung Chun-ying (CY Leung) discusses recent science and technology initiatives like the new Hong Kong University of Science and Technology campus in Guangzhou and the Hong Kong-Shenzhen Innovation and Technology Park, which is set to further foster cooperation between…

UAE Dr Ibtesam Al Bastaki, director of healthcare investment at the Dubai Health Authority (DHA) describes how healthcare investment is flowing into the Emirate via both pure investments and public-private partnerships (PPPs) and the impact of a range of other topics including screening programs, digital health, and healthcare tourism.   PPP…

UAE PhRMA MEA’s Samir Khalil highlights some of the key trends at play across the Middle East and Africa’s dynamic and fast-changing pharmaceutical ecosystem, including several wide-ranging national health transformation plans, the move towards health technology assessment (HTA), and the importance of maintaining robust intellectual property (IP) protection.   We can…

UAE Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, discusses the park’s key milestones and plans for the future, the positive changes in the UAE’s regulatory landscape since COVID, and his excitement about digital health trends and technologies.   At Dubai Science Park, we are proud to play a…

UAE AHK UAE CEO Oliver Oehms gives an overview of German healthcare investment in the Emirates, how the Chamber assists German firms in adjusting to the rapid pace of reform in the UAE, and his hopes for the future of German-Emirati economic cooperation more broadly.   We are confident that the…

Greece Managing Director of MSD Greece, Cyprus & Malta Agata Jakoncic, who also serves as president of Greece’s PhRMA Innovation Forum (PIF), draws on her three decades of industry experience to outline some of the key challenges in the Greek pharma market today which threaten its sustainability and the ability of…